Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-06649751 in early-stage Parkinson's disease
2016-001575-71Phase 2Completed
- Sponsor
- Pfizer
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tavapadon in Parkinson's disease (PD), sponsored by Pfizer. Started Sep 2016; status: completed.
02
Drugs
tavapadon
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2016-001575-71.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001575-71.